Tirzepatide emerges a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://kalewsqk351981.worldblogged.com/46905994/tirzepatide-a-new-frontier-in-diabetes-treatment